CVS Health, IBM tap Watson for chronic disease solution
WOONSOCKET, R.I., and ARMONK, N.Y. — CVS Health and IBM on Thursday announced they will use predictive analytics and Watson cognitive computing for care management services for patients with chronic disease.
The partnership will enable healthcare practitioners to use Watson to advance care management beyond programs and services typically available today. Watson's cognitive computing capabilities interact in natural language, read and understand vast amounts of information, and continuously learn. The offering would enable healthcare practitioners to quickly and easily gain insights from a mix of health information sources, including medical health records, pharmacy and medical claims information, environmental factors and fitness devices to help individuals stay on track with their care and meet health goals.
"CVS Health and IBM are both committed to improving health and finding ways to engage individuals in their well-being through the use of information and technology," said Troyen Brennan, MD, EVP and chief medical officer for CVS Health. "This partnership will enable us to leverage advanced technologies and key health information to develop a tool that can be applied by a variety of healthcare providers, such as pharmacists, nurse practitioners at MinuteClinics or connected healthcare providers, and that can help our pharmacy benefit management clients improve member health and manage cost."
The joint CVS Health/IBM Watson Health solution will be used across a wide range of chronic conditions, including hypertension, heart disease, diabetes and obesity. The offering will be made available to insurers and other entities serving the employer and health plan market and will focus on:
Helping to predict individuals at risk for declining health who may benefit from proactive, customized engagement programs;
Encouraging patients to adopt safe and healthy behaviors, including adherence to prescribed medicines and healthy lifestyle regimens; and
Suggesting appropriate use of cost-effective primary care and out-patient providers.
"The capabilities of the IBM Watson Health Cloud, when coupled with CVS Health's insights into medication utilization and patient behavior, could prove transformative for the industry," said Mike Rhodin, SVP IBM Watson. "Improving care for people with chronic conditions supports IBM's commitment to make big plays that advance the health and well-being of the global community. Through the recent acquisitions of Phytel, Explorys and Curam, we also bring extraordinary capabilities in patient engagement and population health, enabling us to deliver a powerful solution that supports individuals wherever they are, whenever they need it."